BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Elfiky AA, Ismail AM. Molecular modeling and docking revealed superiority of IDX-184 as HCV polymerase inhibitor. Future Virology 2017;12:339-47. [DOI: 10.2217/fvl-2017-0027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Ismail AM, Elfiky AA, Elshemey WM. Recognition of the gluconeogenic enzyme, Pck1, via the Gid4 E3 ligase: An in silico perspective. J Mol Recognit 2019;33. [DOI: 10.1002/jmr.2821] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Elfiky AA. SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective. J Biomol Struct Dyn 2021;39:3204-12. [PMID: 32338164 DOI: 10.1080/07391102.2020.1761882] [Cited by in Crossref: 70] [Cited by in F6Publishing: 89] [Article Influence: 35.0] [Reference Citation Analysis]
3 Elfiky AA, Mahran HA, Ibrahim IM, Ibrahim MN, Elshemey WM. Molecular dynamics simulations and MM-GBSA reveal novel guanosine derivatives against SARS-CoV-2 RNA dependent RNA polymerase. RSC Adv 2022;12:2741-50. [DOI: 10.1039/d1ra07447d] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Dey SK, Saini M, Dhembla C, Bhatt S, Rajesh AS, Anand V, Das HK, Kundu S. Suramin, penciclovir, and anidulafungin exhibit potential in the treatment of COVID-19 via binding to nsp12 of SARS-CoV-2. J Biomol Struct Dyn 2021;:1-17. [PMID: 34784490 DOI: 10.1080/07391102.2021.2000498] [Reference Citation Analysis]